Immune System - Abnormalities - Revision history

Z8600021: /* Introduction */

2019-04-30T00:58:12Z

Introduction

← Older revision		Revision as of 11:58, 30 April 2019
Line 5:		Line 5:

	{{Immune Links}}		{{Immune Links}}
			<br>
			{{Abnormality Links}}

	==Some Recent Findings==		==Some Recent Findings==

Z8600021 at 00:57, 30 April 2019

2019-04-30T00:57:20Z

← Older revision		Revision as of 11:57, 30 April 2019
Line 14:		Line 14:
	\|}		\|}
	{\| class="wikitable mw-collapsible mw-collapsed"		{\| class="wikitable mw-collapsible mw-collapsed"
	! More recent papers		! More recent papers
	\|-		\|-
	\| [[File:Mark_Hill.jpg\|90px\|left]] {{Most_Recent_Refs}}		\| [[File:Mark_Hill.jpg\|90px\|left]] {{Most_Recent_Refs}}

Z8600021 at 00:56, 30 April 2019

2019-04-30T00:56:52Z

← Older revision		Revision as of 11:56, 30 April 2019
Line 20:		Line 20:
	Search term: [http://www.ncbi.nlm.nih.gov/pubmed/?term=Immune+Abnormalities ''Immune Abnormalities '']		Search term: [http://www.ncbi.nlm.nih.gov/pubmed/?term=Immune+Abnormalities ''Immune Abnormalities '']

	~~<pubmed limit=5>Immune Abnormalities </pubmed>~~
	\|}		\|}

Line 43:		Line 42:

	Search term: [http://www.ncbi.nlm.nih.gov/pubmed/?term=Type+1+Diabetes ''Type 1 Diabetes'']		Search term: [http://www.ncbi.nlm.nih.gov/pubmed/?term=Type+1+Diabetes ''Type 1 Diabetes'']

	~~<pubmed limit=5>Type 1 Diabetes</pubmed>~~
	\|}		\|}

Z8600021: /* Type 1 Diabetes */

2015-10-15T23:35:24Z

Type 1 Diabetes

← Older revision		Revision as of 10:35, 16 October 2015
Line 25:		Line 25:
	==Type 1 Diabetes==		==Type 1 Diabetes==

			'''Prevalence of type 1 diabetes among children aged 0–14 in Australia 2013'''<ref name="CVD70">AIHW 2015. [http://www.aihw.gov.au/publication-detail/?id=60129553224&tab=2 Prevalence of type 1 diabetes among children aged 0–14 in Australia 2013]. Diabetes series no. 24. Cat. no. CVD 70. Canberra: AIHW.</ref>
	Prevalence of type 1 diabetes among children aged 0–14 in Australia 2013<ref name="CVD70">AIHW 2015. [http://www.aihw.gov.au/publication-detail/?id=60129553224&tab=2 Prevalence of type 1 diabetes among children aged 0–14 in Australia 2013]. Diabetes series no. 24. Cat. no. CVD 70. Canberra: AIHW.</ref>

	Type 1 diabetes is a non-preventable lifelong autoimmune disease, which is most commonly diagnosed in children. It is a difficult condition to manage, and if left untreated or improperly managed, can lead to many health complications or death. Ongoing, regular monitoring of type 1 diabetes is essential to improve Australia's ability to respond to this important health problem.		Type 1 diabetes is a non-preventable lifelong autoimmune disease, which is most commonly diagnosed in children. It is a difficult condition to manage, and if left untreated or improperly managed, can lead to many health complications or death. Ongoing, regular monitoring of type 1 diabetes is essential to improve Australia's ability to respond to this important health problem.

Z8600021 at 23:34, 15 October 2015

2015-10-15T23:34:45Z

← Older revision		Revision as of 10:34, 16 October 2015
Line 18:		Line 18:
	\| [[File:Mark_Hill.jpg\|90px\|left]] {{Most_Recent_Refs}}		\| [[File:Mark_Hill.jpg\|90px\|left]] {{Most_Recent_Refs}}

	Search term: [http://www.ncbi.nlm.nih.gov/pubmed/?term=~~Type~~+~~1+Diabetes~~ ''~~Type 1 Diabetes~~'']		Search term: [http://www.ncbi.nlm.nih.gov/pubmed/?term=Immune+Abnormalities ''Immune Abnormalities '']

	<pubmed limit=5>~~Type 1 Diabetes~~</pubmed>		<pubmed limit=5>Immune Abnormalities </pubmed>
	\|}		\|}

Line 37:		Line 37:
	* There were 167 Aboriginal and Torres Strait Islander children with type 1 diabetes-equating to 69 cases per 100,000 Indigenous children, or 1 in almost 1,500.		* There were 167 Aboriginal and Torres Strait Islander children with type 1 diabetes-equating to 69 cases per 100,000 Indigenous children, or 1 in almost 1,500.
	* Just over 2 in 5 children (43%) with type 1 diabetes used a pump to administer insulin.		* Just over 2 in 5 children (43%) with type 1 diabetes used a pump to administer insulin.

			{\| class="wikitable mw-collapsible mw-collapsed"
			! Recent Type 1 Diabetes Research
			\|-
			\| [[File:Mark_Hill.jpg\|90px\|left]] {{Most_Recent_Refs}}

			Search term: [http://www.ncbi.nlm.nih.gov/pubmed/?term=Type+1+Diabetes ''Type 1 Diabetes'']

			<pubmed limit=5>Type 1 Diabetes</pubmed>
			\|}

Z8600021 at 23:33, 15 October 2015

2015-10-15T23:33:23Z

← Older revision		Revision as of 10:33, 16 October 2015
Line 18:		Line 18:
	\| [[File:Mark_Hill.jpg\|90px\|left]] {{Most_Recent_Refs}}		\| [[File:Mark_Hill.jpg\|90px\|left]] {{Most_Recent_Refs}}

	Search term: [http://www.ncbi.nlm.nih.gov/pubmed/?term=~~Immune~~+~~System~~+~~Abnormalities~~ ''~~Immune System Abnormalities~~'']		Search term: [http://www.ncbi.nlm.nih.gov/pubmed/?term=Type+1+Diabetes ''Type 1 Diabetes'']

	<pubmed limit=5>~~Immune System Abnormalities~~</pubmed>		<pubmed limit=5>Type 1 Diabetes</pubmed>
	\|}		\|}

Z8600021 at 23:29, 15 October 2015

2015-10-15T23:29:40Z

← Older revision		Revision as of 10:29, 16 October 2015
Line 45:		Line 45:

	* Diabetes Australia - [https://www.diabetesaustralia.com.au/type-1-diabetes Type 1 Diabetes]		* Diabetes Australia - [https://www.diabetesaustralia.com.au/type-1-diabetes Type 1 Diabetes]
			* American Diabetes Association [www.diabetes.org/diabetes-basics/statistics Statistics About Diabetes]


	{{Footer}}		{{Footer}}

Z8600021 at 23:26, 15 October 2015

2015-10-15T23:26:35Z

← Older revision		Revision as of 10:26, 16 October 2015
Line 11:		Line 11:
	\|		\|

	* '''Report - Prevalence of type 1 diabetes among children aged 0–14 in Australia 2013'''<ref name="CVD70">AIHW 2015. [http://www.aihw.gov.au/publication-detail/?id=60129553224&tab=2 Prevalence of type 1 diabetes among children aged 0–14 in Australia 2013]. Diabetes series no. 24. Cat. no. CVD 70. Canberra: AIHW.</ref> "Type 1 diabetes is a non-preventable lifelong autoimmune disease, which is most commonly diagnosed in children. It is a difficult condition to manage, and if left untreated or improperly managed, can lead to many health complications or death. In 2013, 6,091 children aged 0-14 had type 1 diabetes in Australia-representing 139 cases per 100,000 population, or about 1 in every 720 children in that age group. Rates of type 1 diabetes were similar for both boys and girls. Rates for children aged 10-14 were twice as high (278 cases per 100,000 population) as for children aged 5-9 (123 per 100,000), and more than 10 times as high as for children aged 0-4 (27 per 100,000). ~~The Northern Territory had the lowest prevalence of type 1 diabetes in children (50 cases per 100,000 population), while Tasmania had the highest (166 per 100,000)~~. Children living in Remote and very remote areas had the lowest prevalence of type 1 diabetes (82 cases per 100,000 population) compared with all other areas in Australia (where rates varied between 133 and 169 cases per 100,000 population). The prevalence of type 1 ~~diabetes among children was relatively similar across socioeconomic groups. There were 167 Aboriginal and Torres Strait Islander children with type~~ 1 ~~diabetes-equating to 69 cases per 100,000 Indigenous children, or 1 in almost 1,500. Just over 2 in 5 children (43%) with type 1 diabetes used a pump to administer insulin."~~ [[Endocrine - Pancreas Development]] \| [[Immune System Development]]		* '''Report - Prevalence of type 1 diabetes among children aged 0–14 in Australia 2013'''<ref name="CVD70">AIHW 2015. [http://www.aihw.gov.au/publication-detail/?id=60129553224&tab=2 Prevalence of type 1 diabetes among children aged 0–14 in Australia 2013]. Diabetes series no. 24. Cat. no. CVD 70. Canberra: AIHW.</ref> "Type 1 diabetes is a non-preventable lifelong autoimmune disease, which is most commonly diagnosed in children. It is a difficult condition to manage, and if left untreated or improperly managed, can lead to many health complications or death. In 2013, 6,091 children aged 0-14 had type 1 diabetes in Australia-representing 139 cases per 100,000 population, or about 1 in every 720 children in that age group. Rates of type 1 diabetes were similar for both boys and girls. Rates for children aged 10-14 were twice as high (278 cases per 100,000 population) as for children aged 5-9 (123 per 100,000), and more than 10 times as high as for children aged 0-4 (27 per 100,000).." [[#Type 1 Diabetes\|Type 1 Diabetes]] \| [[Endocrine - Pancreas Development]] \| [[Immune System Development]]
	\|}		\|}
	{\| class="wikitable mw-collapsible mw-collapsed"		{\| class="wikitable mw-collapsible mw-collapsed"

Z8600021 at 23:25, 15 October 2015

2015-10-15T23:25:32Z

@@ Line 1: / Line 1: @@
 {{Header}}
 ==Introduction==
 [[File:Stage 22 image 169.jpg|thumb|alt=Developing Human Thymus (Carnegie stage 22)|Developing Human Thymus ([[Carnegie stage 22|stage 22]])]]
@@ Line 13: / Line 10: @@
 |-bgcolor="F5FAFF"
+|
-* '''Tie1 is required for lymphatic valve and collecting vessel development'''<ref name=PMID25576926><pubmed>25576926</pubmed></ref> "Tie1 is a receptor tyrosine kinase with broad expression in embryonic endothelium. Reduction of Tie1 levels in mouse embryos with a hypomorphic Tie1 allele resulted in abnormal lymphatic patterning and architecture, decreased lymphatic draining efficiency, and ultimately, embryonic demise. ... Our findings reveal a fundamental role for Tie signaling during lymphatic vessel remodeling and valve morphogenesis and implicate it as a candidate gene involved in primary lymphedema."
+* '''Report - Prevalence of type 1 diabetes among children aged 0–14 in Australia 2013'''<ref name="CVD70">AIHW 2015. [http://www.aihw.gov.au/publication-detail/?id=60129553224&tab=2 Prevalence of type 1 diabetes among children aged 0–14 in Australia 2013]. Diabetes series no. 24. Cat. no. CVD 70. Canberra: AIHW.</ref> "Type 1 diabetes is a non-preventable lifelong autoimmune disease, which is most commonly diagnosed in children. It is a difficult condition to manage, and if left untreated or improperly managed, can lead to many health complications or death. In 2013, 6,091 children aged 0-14 had type 1 diabetes in Australia-representing 139 cases per 100,000 population, or about 1 in every 720 children in that age group. Rates of type 1 diabetes were similar for both boys and girls. Rates for children aged 10-14 were twice as high (278 cases per 100,000 population) as for children aged 5-9 (123 per 100,000), and more than 10 times as high as for children aged 0-4 (27 per 100,000). The Northern Territory had the lowest prevalence of type 1 diabetes in children (50 cases per 100,000 population), while Tasmania had the highest (166 per 100,000). Children living in Remote and very remote areas had the lowest prevalence of type 1 diabetes (82 cases per 100,000 population) compared with all other areas in Australia (where rates varied between 133 and 169 cases per 100,000 population). The prevalence of type 1 diabetes among children was relatively similar across socioeconomic groups. There were 167 Aboriginal and Torres Strait Islander children with type 1 diabetes-equating to 69 cases per 100,000 Indigenous children, or 1 in almost 1,500. Just over 2 in 5 children (43%) with type 1 diabetes used a pump to administer insulin." [[Endocrine - Pancreas Development]] | [[Immune System Development]]
 |}
 {| class="wikitable mw-collapsible mw-collapsed"
@@ Line 25: / Line 22: @@
 <pubmed limit=5>Immune System Abnormalities</pubmed>
 |}
 {{Footer}}

Z8600021: Created page with "{{Header}} ==Introduction== File:Lymphatic_vessel_development.jpg|thumb|alt=Lymphatic vessel development cartoon|Lymphatic vessel development1..."

2015-10-15T23:20:46Z

Created page with "{{Header}} ==Introduction== File:Lymphatic_vessel_development.jpg|thumb|alt=Lymphatic vessel development cartoon|Lymphatic vessel development<ref name=PMID19138383><pubmed>1..."

New page

{{Header}}
==Introduction==
[[File:Lymphatic_vessel_development.jpg|thumb|alt=Lymphatic vessel development cartoon|Lymphatic vessel development<ref name=PMID19138383><pubmed>19138383</pubmed>| [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646268 PMC2646268] | [http://genomebiology.com/2008/9/12/243 Genome Biology]</ref>]]

[[File:Stage 22 image 169.jpg|thumb|alt=Developing Human Thymus (Carnegie stage 22)|Developing Human Thymus ([[Carnegie stage 22|stage 22]])]]

{{Immune Links}}

==Some Recent Findings==
{|
|-bgcolor="F5FAFF"
|
* '''Tie1 is required for lymphatic valve and collecting vessel development'''<ref name=PMID25576926><pubmed>25576926</pubmed></ref> "Tie1 is a receptor tyrosine kinase with broad expression in embryonic endothelium. Reduction of Tie1 levels in mouse embryos with a hypomorphic Tie1 allele resulted in abnormal lymphatic patterning and architecture, decreased lymphatic draining efficiency, and ultimately, embryonic demise. ... Our findings reveal a fundamental role for Tie signaling during lymphatic vessel remodeling and valve morphogenesis and implicate it as a candidate gene involved in primary lymphedema."

|}
{| class="wikitable mw-collapsible mw-collapsed"
! More recent papers
|-
| [[File:Mark_Hill.jpg|90px|left]] {{Most_Recent_Refs}}

Search term: [http://www.ncbi.nlm.nih.gov/pubmed/?term=Immune+System+Abnormalities ''Immune System Abnormalities'']

<pubmed limit=5>Immune System Abnormalities</pubmed>
|}

{{Footer}}